Alvotech (ALVO) EBITDA Margin (2022 - 2026)
Alvotech (ALVO) posted EBITDA Margin of 18.9% for Q1 2026, down 97.61% on a QoQ basis from 790.72% in Q4 2025, and down 5647.0% year-over-year from 0.34% in Q1 2025.
Alvotech (ALVO) EBITDA Margin (2022 - 2026) Analysis & Trends
Alvotech's EBITDA Margin history runs 5 years deep, the most recent figure standing at 18.9% for Q1 2026.
- Quarterly EBITDA Margin fell 5647.0% year-over-year to 18.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.32% (up 40118.0% YoY) and the FY2025 annual result came in at 28.31%, up 284.0% from the prior year.
- EBITDA Margin was 18.9% for Q1 2026 at Alvotech, down from 790.72% in the prior quarter.
- Across five years, EBITDA Margin topped out at 790.72% in Q4 2025 and bottomed at 15988.05% in Q1 2022.
- A 5-year average of 1739.58% and a median of 390.06% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin jumped 1538118 bps — and 2025, when it tumbled 132854 bps.
- Alvotech's EBITDA Margin stood at 2514.82% in 2022, then climbed by 25 bps to 1877.67% in 2023, then jumped by 85 bps to 291.02% in 2024, then jumped by 372 bps to 790.72% in 2025, then slumped by 98 bps to 18.9% in 2026.
- Business Quant data shows ALVO's EBITDA Margin at 18.9% in Q1 2026, 790.72% in Q4 2025, and 929.24% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 18.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.90% |
| Dec 31, 2025 | 790.72% |
| Sep 30, 2025 | -929.24% |
| Jun 30, 2025 | -9.22% |
| Mar 31, 2025 | 75.37% |
| Dec 31, 2024 | -291.02% |
| Sep 30, 2024 | 399.30% |
| Jun 30, 2024 | -390.06% |
| Mar 31, 2024 | -389.53% |
| Dec 31, 2023 | -1,877.67% |
| Jun 30, 2023 | -608.07% |
| Mar 31, 2023 | -606.87% |
| Dec 31, 2022 | -2,514.82% |
| Jun 30, 2022 | -3,773.51% |
| Mar 31, 2022 | -15,988.05% |